Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis — Stella

Home/Cerebral Venous Thrombosis/

View on ClinicalTrials.gov

Recruiting

Back to Cerebral Venous Thrombosis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Egypt

Kafr Elsheikh University Hospital, Kafr ash Shaykh

Key details

Phase

Large-scale testing

Sponsor

Kafrelsheikh University

Enrollment target

~200 participants

Started

August 2021

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.